About Dong-Gun Kim
Dong-Gun Kim is an executive officer and director at Immunomic Therapeutics.
Dong-Gun Kim first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Dong-Gun Kim in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dong-Gun Kim works with at each company, as listed on that company's latest Form D.
Immunomic Therapeutics, Inc. · Form D, Jun 2, 2025
YJ
Yang Gon Jin
Director
SP
Steve Park
Director
RA
Robert Ahlgren
Director
JW
James Wishart
Director
KA
Ki-Hong Ahn
Director
MC
Matthew Chang
Director